Hearing Impairment in Children

Pediatric Clinics of North America

Volumn 55, Issue 5, 2008, Pages 1175-1188

  Katbamna, Bharti ^a   Crumpton, Teresa ^a   Patel, Dilip R ^a,b,c  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Michigan State University Kalamazoo Center for Medical Studies   (United States)

Author keywords

Early detection; Hearing loss; Infant; Intervention

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CISPLATIN DERIVATIVE; CONNEXIN 26; DIURETIC AGENT; ETACRYNIC ACID; FUROSEMIDE; GENTAMICIN; KANAMYCIN; NEOMYCIN; QUININE DERIVATIVE; SALICYLIC ACID DERIVATIVE; TOBRAMYCIN;

AUDITORY DYSSYNCHRONY; CLINICAL PRACTICE; COCHLEA PROSTHESIS; EARLY DIAGNOSIS; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED OTOACOUSTIC EMISSION; GENE MUTATION; HEARING IMPAIRMENT; HUMAN; LANGUAGE DEVELOPMENT; NEWBORN SCREENING; OTOTOXICITY; PATIENT MONITORING; PEDIATRICIAN; PRACTICE GUIDELINE; PURE TONE AUDIOMETRY; REVIEW; RISK FACTOR; SPEECH DEVELOPMENT; VESTIBULAR DISORDER; VESTIBULOCOCHLEAR NERVE DISEASE;

CHILD, PRESCHOOL; EARLY DIAGNOSIS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING LOSS; HEARING TESTS; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; OTOACOUSTIC EMISSIONS, SPONTANEOUS;

EID: 52949109839     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2008.07.008     Document Type: Review

References (26)

1. Committee on Fetus and Newborn. Joint statement on neonatal screening for hearing impairment. Pediatrics 47 6 (1971) 1085
2. Joint Committee on Infant Hearing position statement. ASHA 24 12 (1982) 1017-1018
3. Early identification of hearing impairment in infants and young children. National Institutes of Health Consensus conference statement. 11 (1993) 1-24
4. American Academy of Pediatrics Task Force on Newborn and Infant Hearing. Newborn and infant hearing loss: detection and intervention. Pediatrics 103 (1999) 527-529
5. Yoshinaga-Itano C., Sedey A.L., Coulter D.K., et al. Language of early- and later-identified children with hearing loss. Pediatrics 102 5 (1998) 1161-1171
6. Downs M.P., and Yoshinaga-Itano C. The efficacy of early identification and intervention for children with hearing impairment. Pediatr Clin North Am 46 1 (1999) 79-87
7. Yoshinaga-Itano C. Early intervention after universal neonatal hearing screening: impact on outcomes. Ment Retard Dev Disabil Res Rev 9 4 (2003) 252-266
8. Joint Committee on Infant Hearing. Year 2007 position statement: principles and guidelines for early hearing detection and intervention program. Pediatrics 120 4 (2007) 898-921
9. Rea P.A., and Gibson W.P. Evidence of surviving outer hair cell function in congenitally deaf ears. Laryngoscope 113 (2003) 2030-2034
10. Starr A., Isaacson B., Michaelewski H., et al. A dominantly inherited progressive deafness affecting distal auditory nerve and hair cells. J Assoc Res Otolaryngol 5 (2004) 411-426
11. Starr A., Picton T.W., and Kim R. Pathophysiology of auditory neuropathy. In: Sininger Y., and Starr A. (Eds). Auditory neuropathy: new perspectives in hearing disorders (2001), Singular-Thomson Learning, San Diego (CA) 67-82
12. Rance G. Auditory neuropathy/dys-synchrony and its perceptual consequences. Trends Amplif 9 (2005) 1-43
13. Hall III J.W. Clinical applications of OAEs in children. In: Danhauer JL. (Ed). Handbook of otoacoustic emissions (2000), Singular-Thomson Learning, San Diego (CA) 389-480
14. Starr A., Michaelewski H.J., Zeng F.-G., et al. Pathology and physiology of auditory neuropathy with a novel mutation in the MPZ gene (tyr145→Ser). Brain 126 (2003) 1604-1619
15. Oysu C., Aslan I., Basaran B., et al. The site of hearing loss in Refsum's disease. Int J Pediatr Otorhinolaryngol 16 (2001) 129-134
16. Satya-Murti S., Cacace A., and Hanson P. Auditory dysfunction in Friedreich ataxia: result of spiral ganglion degeneration. Neurology 30 (1980) 1047-1053
17. Zwirner P., and Wilichowski E. Progressive sensorineural hearing loss in children with mitochondrial encephalomyopathies. Laryngoscope 111 (2001) 515-521
18. Okumura T., Takahashi H., Honjo I., et al. Sensorineural hearing loss in patients with large vestibular aqueduct. Laryngoscope 105 (1995) 289-294
19. Callison D.M., and Horn K.L. Large vestibular aqueduct syndrome: an overlooked etiology for progressive childhood hearing loss. J Am Acad Audiol 9 (1998) 285-291
20. National Institutes for Deafness and Other Communication Disorders. Pendred syndrome. (2007). http://www.nidcd.nih.gov/health/hearing/ Accessed April 16, 2008
21. Smith R., and Van Camp G. Pendred syndrome/DFN4 (2006). Available at: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=gene.chapter.pendred Accessed April 16, 2008
22. Pryor S.P., Madeo A.C., Reynolds J.C., et al. SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet 42 (2005) 159-165
23. Merchant S.N., Nakajima H.H., Halpin C., et al. Clinical investigation and mechanism of air-bone gaps in large aqueduct syndrome. Ann Otol Rhinol Laryngol 116 (2007) 532-541
24. Cyrns K., Orzan E., Murgia A., et al. A genotype-phenotype correlation for GBJ2 (connexin 26) deafness. J Med Genet 41 (2004) 147-154
25. Cohn E.S., Kelley P.M., Fowler T.W., et al. Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1). Pediatrics 103 (1999) 546-550
26. Smith R.J., Bale J.F., and White K.R. Sensorineural hearing loss in children. Lancet 365 (2005) 879-890